SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-008513
Filing Date
2022-03-02
Accepted
2022-03-02 08:15:10
Documents
2
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1535
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3992
  Complete submission text file 0000899243-22-008513.txt   7015
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Issuer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Gruia Gabriela (Reporting) CIK: 0001860326 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32979 | Film No.: 22701429